Orient Pharma Co., Ltd. (4166.TWO)

TWD 37.1

(-2.5%)

Market Cap (In TWD)

8.27 Billion

Revenue (In TWD)

889.91 Million

Net Income (In TWD)

22.28 Million

Avg. Volume

45.8 Thousand

Currency
TWD
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
19.45-50.7
PE
-
EPS
-
Beta Value
0.048
ISIN
TW0004166004
CUSIP
-
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Yi Xin Zhang
Employee Count
-
Website
https://www.oppharma.com
Ipo Date
2012-06-20
Details
Orient Pharma Co., Ltd. engages in the research and development, manufacturing, and sales of drugs in Taiwan and internationally. The company develops anti-psychotics and psychostimulants, as well as drugs for treating Parkinson's and Alzheimer's diseases; and products for the treatment of sialorrhea, tuberculosis, and attention deficit hyperactivity disorder. It is also developing drug delivery technologies, such as multi-stages-controlled release technology, trans-dermal patches, oral disintegrating tablets, sustained release technology, and micro granules. The company was founded in 2008 and is based in Taipei, Taiwan.